Pharmaceutical compositions comprising DGLA and use of same
US9682055B2 · kind B2 · utility
7Cited by
2References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2015 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | Jun 4, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61Q19/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.